| Predicate |
Object |
| contentType |
English Abstract|Journal Article|Review |
| endingPage |
41 |
| issn |
0003-410X |
| issueIdentifier |
7 Suppl |
| pageRange |
2S37-41 |
| publicationName |
Annales de medecine interne |
| startingPage |
2S37 |
| bibliographicCitation |
Noble F. [Bupropion: risks and advantages of its use. What preclinical research says]. Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S37–41. PMID: 12518081. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4497-0212 |
| date |
200211 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/12518081 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0003-410X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/603 |
| language |
French |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
[Bupropion: risks and advantages of its use. What preclinical research says] |
| discusses |
http://id.nlm.nih.gov/mesh/M0025361
http://id.nlm.nih.gov/mesh/M0028000 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D018687Q000627
http://id.nlm.nih.gov/mesh/D016540
http://id.nlm.nih.gov/mesh/D016642Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D016642Q000009
http://id.nlm.nih.gov/mesh/D012307
http://id.nlm.nih.gov/mesh/D000818 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594 |